BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• Press Releases

  Purespring Therapeutics raises £80/$105 million in a Series B financing to transform the treatment of kidney diseases

  October 10, 2024

   · 

  6 min read
• Press Releases

  Centivax Selects Global CDMO BioCina to Initiate cGMP Manufacturing of Revolutionary Universal Influenza Vaccine

  October 10, 2024

   · 

  3 min read
• Press Releases

  Laxxon Medical to Attend CPHI Milan 2024, Showcasing the cGMP Printing Technology at Adare Pharma Solution’s Facility in Pessano, Italy

  October 10, 2024

   · 

  2 min read
• Press Releases

  TeDan Surgical Innovations Launches Phantom ML3™ MIS Lumbar Surgical Access System, Offering Simplicity Without Compromising Versatility in Minimally Invasive TLIF Procedures

  October 10, 2024

   · 

  2 min read
• Press Releases

  10x Genomics Announces Preliminary Select Third Quarter 2024 Results

  October 10, 2024

   · 

  6 min read
• Press Releases

  Pfizer Declares Fourth-Quarter 2024 Dividend

  October 10, 2024

   · 

  1 min read
• Press Releases

  Arcus Biosciences Announces New Employment Inducement Grants - October 9, 2024

  October 10, 2024

   · 

  1 min read
• Press Releases

  Daewoong Pharmaceutical Unveils ‘Innovative Drug Delivery Technologies’ in Milan--From World’s First Microneedle Therapy to Once-a-Month Obesity Treatment

  October 10, 2024

   · 

  3 min read
• Press Releases

  Harbour BioMed Announces Publication of the Phase I Study Results for Porustobart in Combination with Toripalimab in Advanced Melanoma and Other Solid Tumors

  October 10, 2024

   · 

  5 min read
• Press Releases

  Roche obtains CE certification for the first companion diagnostic to identify patients with gastric and gastroesophageal junction cancer eligible for targeted treatment with VYLOY

  October 10, 2024

   · 

  5 min read